Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 4251-4260 Newer>

The Motley Fool October 22, 2007 Brian Lawler	Not Another Pfizer Pfailure As Pfizer's top execs have said before, losing patent protections on many of its top products around the same time makes for a difficult operating environment. Pfizer's third-quarter results showed just how difficult those losses were.
Fast Company November 1, 2007 Tinker Ready	Drug Flow and Deal Flow The news at this year's Biotech Investing confab will focus on Big Pharma companies, as they take a more active role in developing early-stage drugs.
The Motley Fool October 19, 2007 Billy Fisher	Keeping Pace at St. Jude Medical device maker St. Jude Medical has a strong quarter, but investors weren't impressed.
The Motley Fool October 19, 2007 Brian Orelli	Baxter Gets Pumped Up Medical-device maker Baxter puts in a nice quarter despite two recent FDA recalls.
The Motley Fool October 19, 2007 Brian Lawler	Schering's Gain Is Only a Mild Headache for Vertex Schering-Plough's strong phase 2 clinical results of its hepatitis C virus drug candidate send shares of competitor Vertex down.
The Motley Fool October 19, 2007 Brian Lawler	The Exubera Winner In its third-quarter earnings report, Pfizer announces it is surrendering the rights to market inhalable-insulin treatment Exubera to developer Nektar Therapeutics. Investors, take note.
The Motley Fool October 19, 2007 Billy Fisher	Defying Intuition at Intuitive Surgical Another round of good quarterly results brings another boost in surgical robot maker Intuitive Surgical's stock price. Investors, take note.
The Motley Fool October 19, 2007 Anders Bylund	Intuitive Surgical Cuts a Colossal Check: Fool by Numbers The fast facts on the third-quarter results from Intuitive Surgical; the surgical robot maker is building up a strong balance sheet, with no debt to speak of and a hefty cash position. Investors, take note.
The Motley Fool October 19, 2007 Billy Fisher	Wyeth's Resilience Wyeth's latest quarter is an outstanding example of the drugmaker's consistency; the company reports solid results from all of its businesses, along with a 9% increase in sales.
National Defense November 2007 Grace Jean	Remotely Sensing Soldiers' Distress With the advent of personal handheld electronics and the miniaturization of components, the ability to package medical sensors inside palm-sized devices has allowed remote welfare monitoring systems to become feasible in war zones.
<Older 4251-4260 Newer> Return to current articles.